126 related articles for article (PubMed ID: 8742979)
21. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
Sugiyama S; Miyata T; Inagi R; Kurokawa K
Int J Mol Med; 1998 Nov; 2(5):561-5. PubMed ID: 9858652
[TBL] [Abstract][Full Text] [Related]
22. Beta-2 microglobulin in ESRD: an in-depth review.
Winchester JF; Salsberg JA; Levin NW
Adv Ren Replace Ther; 2003 Oct; 10(4):279-309. PubMed ID: 14681859
[TBL] [Abstract][Full Text] [Related]
23. Beta 2-microglobulin amyloidosis: role of monocytes/macrophages.
Hou FF; Owen WF
Curr Opin Nephrol Hypertens; 2002 Jul; 11(4):417-21. PubMed ID: 12105392
[TBL] [Abstract][Full Text] [Related]
24. [Beta 2-microglobulin amyloidosis].
Mazanec K; McClure J; Bartley CJ; Newbould MJ
Cesk Patol; 1992 Mar; 28(1):42-7. PubMed ID: 1596944
[TBL] [Abstract][Full Text] [Related]
25. Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis.
Montagna G; Cazzulani B; Obici L; Uggetti C; Giorgetti S; Porcari R; Ruggiero R; Mangione PP; Brambilla M; Lucchetti J; Guiso G; Gobbi M; Merlini G; Salmona M; Stoppini M; Villa G; Bellotti V
Amyloid; 2013 Sep; 20(3):173-8. PubMed ID: 23734692
[TBL] [Abstract][Full Text] [Related]
26. Amyloid deposition in systemic organs in long-term hemodialysis patients.
Ogawa H; Saito A; Hirabayashi N; Hara K
Clin Nephrol; 1987 Oct; 28(4):199-204. PubMed ID: 3319310
[TBL] [Abstract][Full Text] [Related]
27. Morphological and immunohistochemical findings in dialysis-related amyloidosis. An analysis of 16 cases.
Solé M; Cardesa A; Palacín A; Muñoz-Gómez J; Campistol JM
Appl Pathol; 1989; 7(6):350-60. PubMed ID: 2701266
[TBL] [Abstract][Full Text] [Related]
28. The advanced glycation endproduct, pentosidine, in the carpal ligament in patients with carpal tunnel syndrome undergoing hemodialysis: comparison with idiopathic carpal tunnel syndrome.
Takahashi M; Hoshino H; Kushida K; Murata H; Baba S; Inoue T
Nephron; 1998 Dec; 80(4):444-9. PubMed ID: 9832644
[TBL] [Abstract][Full Text] [Related]
29. Modification of beta 2-microglobulin with D-glucose or 3-deoxyglucosone inhibits A beta 2M amyloid fibril extension in vitro.
Hashimoto N; Naiki H; Gejyo F
Amyloid; 1999 Dec; 6(4):256-64. PubMed ID: 10611946
[TBL] [Abstract][Full Text] [Related]
30. 'Carbonyl stress' and dialysis-related amyloidosis.
Miyata T; Ueda Y; Saito A; Kurokawa K
Nephrol Dial Transplant; 2000; 15 Suppl 1():25-8. PubMed ID: 10737163
[TBL] [Abstract][Full Text] [Related]
31. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
Miyata T
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
[TBL] [Abstract][Full Text] [Related]
32. Amyloidosis, advanced glycation end products and Alzheimer disease.
Smith MA; Monnier VM; Sayre LM; Perry G
Neuroreport; 1995 Aug; 6(12):1595-6. PubMed ID: 8527721
[No Abstract] [Full Text] [Related]
33. beta2-microglobulin-derived amyloidosis: an update.
Floege J; Ketteler M
Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of beta(2)-microglobulin amyloidosis: role of monocytes/macrophages.
Hou FF; Reddan DN; Seng WK; Owen WF
Semin Dial; 2001; 14(2):135-9. PubMed ID: 11264784
[TBL] [Abstract][Full Text] [Related]
35. Electron-microscopic and immunohistochemical study of beta-2-microglobulin-related amyloidosis.
Nishi S; Ogino S; Maruyama Y; Honma N; Gejyo F; Morita T; Arakawa M
Nephron; 1990; 56(4):357-63. PubMed ID: 1706823
[TBL] [Abstract][Full Text] [Related]
36. [Morphology and diagnosis of hemodialysis--related amyloidosis].
Ohashi K; Kawai R; Hara M
Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770
[No Abstract] [Full Text] [Related]
37. [A histological study on the synovial tissue of rat knee joints in the experimental beta 2-microglobulin derived amyloidosis].
Ueda T
Ryumachi; 1992 Aug; 32(4):308-17. PubMed ID: 1411793
[TBL] [Abstract][Full Text] [Related]
38. Chemical heterogeneity of amyloid in the carpal tunnel syndrome.
Stein K; Störkel S; Linke RP; Goebel HH
Virchows Arch A Pathol Anat Histopathol; 1987; 412(1):37-45. PubMed ID: 3120402
[TBL] [Abstract][Full Text] [Related]
39. Beta-2-microglobulin amyloidosis and renal bone disease.
Drüeke TB
Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
[TBL] [Abstract][Full Text] [Related]
40. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts.
Owen WF; Hou FF; Stuart RO; Kay J; Boyce J; Chertow GM; Schmidt AM
Kidney Int; 1998 May; 53(5):1365-73. PubMed ID: 9573554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
